(84 days)
Not Found
No
The description focuses on standard medical device functionalities like infusion control, monitoring (SpO2, pulse rate), and safety features within an MRI environment. There is no mention of AI, ML, or related concepts like learning, adaptation, or complex pattern recognition beyond basic calculations and alarm thresholds.
No
Explanation: The device is an infusion pump and monitoring system used for administering fluids and monitoring vital signs. While these functions are supportive in a medical setting, they do not directly treat a disease or condition but rather facilitate other medical procedures (MRI scans, fluid administration).
Yes
The device includes a Pulse Oximeter feature that measures, displays, and records functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate, which are diagnostic physiological parameters.
No
The device description clearly details physical hardware components such as a peristaltic pump channel, motor, display, power supply, battery, and processor/memory functions. It also mentions optional hardware like a second pump channel and a remote display. While software is integral to its operation (controls, display, processor functions, Dose Rate Calculator, Drug Library), the device is fundamentally a physical infusion pump and monitoring system with integrated hardware.
Based on the provided text, the device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The MRidium 3860 MRI Infusion Pump/Monitoring System is primarily an infusion pump used to administer fluids to patients. It also includes a pulse oximeter for monitoring physiological parameters (SpO2 and pulse rate).
- Lack of Sample Analysis: The device does not perform any analysis on samples taken from the patient's body. It delivers substances into the body and monitors physiological signals from the body.
Therefore, the device falls under the category of a therapeutic and monitoring medical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The Iradimed Corporation's MRidium 3860 MRI Infusion Pump/Monitoring System is intended for:
- · General hospital or clinical use by medical professionals whenever it is required to infuse 해 patients with subcutaneous, intra-venous or intra-arterial fluids before, during, or after Magnetic Resonance Imaging (MRI) scans, functioning while either in a stationary or mobile position.
- The system is useful in the administration of fluids requiring precisely controlled infusion rates. The system can operate in either continuous, intermittent, or bolus delivery mode.
- The Infusion Pump can be used inside the MRI room mounted outside the 10,000 Gauss line (1 Tesla line), and with shielded magnets of field strength of 3.0 Tesla or less. 4.
- This device is available for sale only upon the order of a physician or other related
- licensed medical professional, and not intended for any home use applications.
- The Pulse Oximeter is used to measure, display, and record functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult, pediatric, and infant patients in an MR environment. Testing of the oximeter was performed in MR conditional environments at 1.5T and 3T. It is indicated for spot checking and/or continuous monitoring of patients who are well or poorly perfused in the MRI.
The infusion pump is contraindicated for use on the inlet side of Extracorporeal Membrane Oxygenation (ECMO) systems where the negative pressure is greater than -100 mmHz as the high negative pressures can result in uncontrolled fluid flow.
Product codes (comma separated list FDA assigned to the subject device)
FRN
Device Description
The MRidium 3860 MRI Infusion Pump/Monitoring System is an MRI compatible IV pump intended for use within the MR Scan room. The device shall operate to full specification in magnetic fields of up to 10,000 gauss and have RF emissions at the Larmor frequencies up to and including 3.0 Tesla MR scanners such that image signal to noise is not visibly affected with the pump within 1 foot from the MRI bore opening. The magnetic content of the device is minimal so as to avoid any hazard of magnetic attraction.
The pump unit is designed with an integral single peristaltic pump channel utilizing an ultrasonic (non-magnetic) motor. This integral channel is vertically oriented to the right side of the unit. The main assembly of the pump unit shall contain the controls, display, power supply, battery, and processor/memory functions suitable to meet the complete and expanded system requirements.
The left side of the unit is designed to accommodate attachment of an optional second peristalitic pump channel which is controlled through the main pump assembly's display and controls. A remote display is also available for independent viewing and control from the adjacent MRI Control areas.
The Dose Rate Calculator feature, allows the user to set a patient's infusion rate based upon a user selected parameters, including volume to be infused, dose, concentration, weight, and/or time.
Additionally, the Dose Rate Calculator feature with the Drug Library option, allows the user to choose a patient's infusion protocol using user selected parameters, including volume to be infused, dose, concentration, weight, and/or time. The Drug Library includes common medications most frequently infused during MRI procedures. This Drug Library option feature can only be activated with a service-related, limited user access menu.
The Pulse Oximeter feature of the 3860 MRI Infusion Pump/Monitoring System is used in measuring, displaying, and recording functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult, pediatric, and infant patients in an MR environment. Testing was performed in MR conditional environments at 1.5T and 3T. It is indicated for continuous monitoring of patients in the MRI who are well or poorly perfused. The 3860 System displays the patient's pulse rate and SpO2 values, as well as applicable alarm limits. The 3860 System includes adjustable audible and visual pulse rate and oxygen saturation (SpO2) alarms. It also includes a variety of additional features, including low battery alarms, status indicators and sensor-related alarms. The 3860 System only uses fiberoptic SpO2 sensors. These fiber optic sensors, cables, and associated finger wrap accessories contain no conductive components, they can safely be placed on the patient's finger while inside an MR (magnetic resonance) environment.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult, pediatric, and infant patients
Intended User / Care Setting
General hospital or clinical use by medical professionals
MRI room
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Functional and Safety Testing: The 3860 MRI Infusion Pump/Monitoring System has successfully undergone testing in order to demonstrate that it has appropriate functional features and is substantially equivalent to the predicate devices. Additionally, the pulse oximeter feature and fiberoptic sensor components of the 3860 System have successfully undergone both bench and clinical testing in order to demonstrate that it has appropriate functional features needed to demonstrate the safety and effectiveness of the system.
The conclusions drawn from these nonclinical tests demonstrate that the device is safe and effective, and performs as well or better that the predicate device.
Tests demonstrating consideration and mitigation of the identified potential hazards for this device have been completed, along with the design reviews, product verification and validation testing performed prior to product release.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
MRidium 3850 Infusion Pump System (K050301), Nonin 7500FO Pulse Oximeter, Medrad Continuum Infusion Pump System (510(k) numbers K032771, K021988, and K061128), Alaris PC-1 Infusion Pump System (510(k) number K012383), CME Bodyguard 323 Infusion Pump with Pulse Oximeter (K060479)
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5725 Infusion pump.
(a)
Identification. An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.(b)
Classification. Class II (performance standards).
0
Kofioos
1 of 3
510(k) Summary of Safety and Effectiveness
Submitter Information:
Iradimed Corporation 7457 Aloma Ave. Suite 201 Winter Park, FL 32972
APR - 7 2009
407-677-8022 ext. 106 Contact: Mr. Francis Casey
Date Prepared: January 5, 2009
Product Name:
Proprietary: MRidium 3860 MRI Infusion Pump/Monitoring System Common: Infusion Pump and Infusion Sets, and Pulse Oximeter. Classification: Class II (see 21 CFR - 870.5725 and 870.2700).
Predicate Devices:
The predicate device(s) are: MRidium 3850 Infusion Pump System (K050301); Nonin 7500FO Pulse Oximeter; the Medrad Continuum Infusion Pump System (510(k) numbers K032771, K021988, and K061128); Alaris PC-1 Infusion Pump System (510(k) number K012383); the CME Bodyguard 323 Infusion Pump with Pulse Oximeter (K060479); The MRidium 3860 Infusion Pump System is substantially equivalent to these predicate devices.
Device Description:
The MRidium 3860 MRI Infusion Pump/Monitoring System is an MRI compatible IV pump intended for use within the MR Scan room. The device shall operate to full specification in magnetic fields of up to 10,000 gauss and have RF emissions at the Larmor frequencies up to and including 3.0 Tesla MR scanners such that image signal to noise is not visibly affected with the pump within 1 foot from the MRI bore opening. The magnetic content of the device is minimal so as to avoid any hazard of magnetic attraction.
The pump unit is designed with an integral single peristaltic pump channel utilizing an ultrasonic (non-magnetic) motor. This integral channel is vertically oriented to the right side of the unit. The main assembly of the pump unit shall contain the controls, display, power supply, battery, and processor/memory functions suitable to meet the complete and expanded system requirements.
1
The left side of the unit is designed to accommodate attachment of an optional second peristalitic pump channel which is controlled through the main pump assembly's display and controls. A remote display is also available for independent viewing and control from the adjacent MRI Control areas.
The Dose Rate Calculator feature, allows the user to set a patient's infusion rate based upon a user selected parameters, including volume to be infused, dose, concentration, weight, and/or time.
Additionally, the Dose Rate Calculator feature with the Drug Library option, allows the user to choose a patient's infusion protocol using user selected parameters, including volume to be infused, dose, concentration, weight, and/or time. The Drug Library includes common medications most frequently infused during MRI procedures. This Drug Library option feature can only be activated with a service-related, limited user access menu.
The Pulse Oximeter feature of the 3860 MRI Infusion Pump/Monitoring System is used in measuring, displaying, and recording functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult, pediatric, and infant patients in an MR environment. Testing was performed in MR conditional environments at 1.5T and 3T. It is indicated for continuous monitoring of patients in the MRI who are well or poorly perfused. The 3860 System displays the patient's pulse rate and SpO2 values, as well as applicable alarm limits. The 3860 System includes adjustable audible and visual pulse rate and oxygen saturation (SpO2) alarms. It also includes a variety of additional features, including low battery alarms, status indicators and sensor-related alarms. The 3860 System only uses fiberoptic SpO2 sensors. These fiber optic sensors, cables, and associated finger wrap accessories contain no conductive components, they can safely be placed on the patient's finger while inside an MR (magnetic resonance) environment.
Intended Uses:
The Iradimed Corporation's MRidium 3860 MRI Infusion Pump/Monitoring System is intended for general hospital or clinical use by medical professionals whenever it is required to infuse patients with intra-venous or intra-arterial fluids before, during, or after Magnetic Resonance Imaging (MRI) scans, functioning while either in a stationary or mobile position. This device is available for sale only upon the order of a physician or other related licensed medical professional, and not intended for any home use applications.
The Pulse Oximeter is used to measure, display, and record functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult, pediatric, and infant patients in an MR environment. Testing of the oximeter was performed in MR conditional environments at 1.5T and 3T. It is indicated for spot-checking and/or continuous monitoring of patients who are well or poorly perfused in the MRI.
2
Technological Comparison to Predicate Device(s):
The Iradimed Corporation MRidium 3860 MRI Infusion Pump/Monitoring System uses similar types of technology that are found in the predicate devices listed above, and are enumerated in Attachment 3 of this document.
A comparison of the technological characteristics of the MRidium 3860 MRI Infusion Pump/Monitoring System and the predicate device has been performed. The results of this comparison demonstrate that the MRidium 3860 MRI Infusion Pump/Monitoring System is equivalent in technological characteristics and the fundamental scientific technology of the predicate device.
Summary of Performance Testing:
The Iradimed Corporation's MRidium 3860 MRI Infusion Pump/Monitoring System conforms with national and available international product safety standards for medical device general safety, infusion therapy, pulse oximetry, electrical safety, and electromagnetic compatibility.
Functional and Safety Testing: The 3860 MRI Infusion Pump/Monitoring System has successfully undergone testing in order to demonstrate that it has appropriate functional features and is substantially equivalent to the predicate devices. Additionally, the pulse oximeter feature and fiberoptic sensor components of the 3860 System have successfully undergone both bench and clinical testing in order to demonstrate that it has appropriate functional features needed to demonstrate the safety and effectiveness of the system.
The conclusions drawn from these nonclinical tests demonstrate that the device is safe and effective, and performs as well or better that the predicate device.
Tests demonstrating consideration and mitigation of the identified potential hazards for this device have been completed, along with the design reviews, product verification and validation testing performed prior to product release.
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three heads, representing the department's commitment to health, human services, and well-being. The eagle is encircled by the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA". The logo is in black and white.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Iradimed Corporation APR - 7 7009 C/o Mr. Robert Mosenkis President CITECH 5200 Butler Pike Plymouth Meeting, Pennsylvania 19462
Re: K090087
Trade/Device Name: Iradimed Corporation MRidium 3860 series MRI Infusion Pump/Monitoring System Regulation Number: 21 CFR 880.5725 Regulation Name: Infusion Pump Regulatory Class: II Product Code: FRN Dated: March 25, 2009 Received: March 26, 2009
Dear Mr. Mosenkis:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Mr. Mosenkis
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Shala N Murphy, RD for S. Rumer DDS
Susan Runner, D.D.S., MA Acting Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
510(k) Number (if known): K090087
Device Name: Iradimed Corporation MRidium 3860 series MRI Infusion Pump/Monitoring System
Indications For Use: The MRidium 3860 Series MRI Infusion Pump/Monitoring System indications for use are as follows:
Intended Uses:
The Iradimed Corporation's MRidium 3860 MRI Infusion Pump/Monitoring System is intended for:
- · General hospital or clinical use by medical professionals whenever it is required to infuse 해 patients with subcutaneous, intra-venous or intra-arterial fluids before, during, or after Magnetic Resonance Imaging (MRI) scans, functioning while either in a stationary or mobile position.
- The system is useful in the administration of fluids requiring precisely controlled infusion rates. The system can operate in either continuous, intermittent, or bolus delivery mode.
- The Infusion Pump can be used inside the MRI room mounted outside the 10,000 Gauss line (1 Tesla line), and with shielded magnets of field strength of 3.0 Tesla or less. 4.
- This device is available for sale only upon the order of a physician or other related
- licensed medical professional, and not intended for any home use applications.
- The Pulse Oximeter is used to measure, display, and record functional oxygen saturation of arterial hemoglobin (SpO2) and pulse rate of adult, pediatric, and infant patients in an MR environment. Testing of the oximeter was performed in MR conditional environments at 1.5T and 3T. It is indicated for spot checking and/or continuous monitoring of patients who are well or poorly perfused in the MRI.
The infusion pump is contraindicated for use on the inlet side of Extracorporeal Membrane Oxygenation (ECMO) systems where the negative pressure is greater than -100 mmHz as the high negative pressures can result in uncontrolled fluid flow.
Prescription Use X
(Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Anesthesiology, General Hospital Infection Control, Dental Devices
510(k) Number: K092527
Page 1 of 1